Ghrelin: New insight to mechanisms and treatment of postoperative gastric ileus

Current Pharmaceutical Design

Volumn 17, Issue 16, 2011, Pages 1587-1593

  Stengel, Andreas ^a,b   Tachéa, Yvette ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Abdominal surgery; Desacyl ghrelin; Drug treatment; Ghrelin O acyltransferase; GOAT

Indexed keywords

ACYLTRANSFERASE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CORTICOTROPIN RELEASING FACTOR; DESACYL GHRELIN; GASTROINTESTINAL HORMONE; GHRELIN; GHRELIN O ACYLTRANSFERASE; GHRELIN RECEPTOR; GROWTH HORMONE; GSK 894281; HORMONE ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR AGONIST; NITRIC OXIDE; OXIDOPAMINE; PROKINETIC AGENT; PROTIRELIN[3 (3,3 DIMETHYLPROLINAMIDE)]; RC 1139; S 346011; S 406028; ULIMORELIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL SURGERY; ACYLATION; ANTIINFLAMMATORY ACTIVITY; CELL PROLIFERATION; CLINICAL TRIAL; FOOD INTAKE; GASTROINTESTINAL MOTILITY; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; ILEUS; INTESTINE TRANSIT TIME; LIPOPHILICITY; MUSCLE CONTRACTION; NODOSE GANGLION; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE GASTRIC ILEUS; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STOMACH EMPTYING; VAGUS TONE;

ABDOMEN; ANIMALS; ENERGY INTAKE; GASTROINTESTINAL MOTILITY; GHRELIN; HUMANS; ILEUS; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE;

EID: 79960024164     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211796196990     Document Type: Review

References (137)

1. Luckey A, Livingston E, Taché Y. Mechanisms and treatment of postoperative ileus. Arch Surg 2003; 138: 206-14.
2. Livingston EH, Passaro EP, Jr. Postoperative ileus. Dig Dis Sci 1990; 35: 121-32.
3. Kehlet H. Postoperative ileus--an update on preventive techniques. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 552-8.
4. Delaney CP, Senagore AJ, Viscusi ER, et al. Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials. Am J Surg 2006; 191: 315-19.
5. Benson MJ, Wingate, DL. Ileus and mechanical obstruction. In: Kumar D, Wingate, D. L., ed. An illustrated guide to gastrointestinal motility. London: Churchill Livingston 1993: 547-66.
6. Zeinali F, Stulberg JJ, Delaney CP. Pharmacological management of postoperative ileus. Can J Surg 2009; 52: 153-7.
7. Asgeirsson T, El-Badawi KI, Mahmood A, Barletta J, Luchtefeld M, Senagore AJ. Postoperative ileus: it costs more than you expect. J Am Coll Surg 2010; 210: 228-31.
8. Bueno L, Fioramonti J, Ruckebusch Y. Postoperative intestinal motility in dogs and sheep. Am J Dig Dis 1978; 23: 682-9.
9. Kalff JC, Buchholz BM, Eskandari MK, Hierholzer C, Schraut WH, Simmons RL, Bauer AJ. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 1999; 126: 498-509.
10. Kalff JC, Carlos TM, Schraut WH, Billiar TR, Simmons RL, Bauer AJ. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999; 117: 378-87.
11. Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut 2009; 58: 1300-11.
12. Nilsson F, Jung B. Gastric evacuation and small bowel propulsion after laparotomy. A study with a double isotope technique in rat. Acta Chir Scand 1973; 139: 724-30.
13. Dubois A, Weise VK, Kopin IJ. Postoperative ileus in the rat: physiopathology, etiology and treatment. Ann Surg 1973; 178: 781-6.
14. Boeckxstaens GE, Hirsch DP, Kodde A, et al. Activation of an adrenergic and vagally-mediated NANC pathway in surgeryinduced fundic relaxation in the rat. Neurogastroenterol Motil 1999; 11: 467-74.
15. Espat NJ, Cheng G, Kelley MC, Vogel SB, Sninsky CA, Hocking MP. Vasoactive intestinal peptide and substance P receptor antagonists improve postoperative ileus. J Surg Res 1995; 58: 719-23.
16. De Winter BY, Robberecht P, Boeckxstaens GE, et al. Role of VIP1/PACAP receptors in postoperative ileus in rats. Br J Pharmacol 1998; 124: 1181-6.
17. Plourde V, St-Pierre S, Fournier A, Taché Y. CGRP 8- 37[correction of 8-27] blocks the inhibition of gastric emptying induced by intravenous injection of alpha-CGRP in rats. Life Sci 1993; 52: 857-62.
18. Bonaz B, Taché Y. Corticotropin-releasing factor and systemic capsaicin-sensitive afferents are involved in abdominal surgeryinduced Fos expression in the paraventricular nucleus of the hypothalamus. Brain Res 1997; 748: 12-20.
19. Zittel TT, Lloyd KC, Rothenhofer I, Wong H, Walsh JH, Raybould HE. Calcitonin gene-related peptide and spinal afferents partly mediate postoperative colonic ileus in the rat. Surgery 1998; 123: 518-27.
20. Freeman ME, Cheng G, Hocking MP. Role of alpha- and betacalcitonin gene-related peptide in postoperative small bowel ileus. J Gastrointest Surg 1999; 3: 39-43.
21. Plourde V, Wong HC, Walsh JH, Raybould HE, Taché Y. CGRP antagonists and capsaicin on celiac ganglia partly prevent postoperative gastric ileus. Peptides 1993; 14: 1225-9.
22. Pappas T, Debas H, Taché Y. Corticotropin-releasing factor inhibits gastric emptying in dogs. Regul Pept 1985; 11: 193-9.
23. Taché Y, Maeda-Hagiwara M, Turkelson CM. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am J Physiol 1987; 253: G241-5.
24. Lenz HJ, Burlage M, Raedler A, Greten H. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology 1988; 94: 598-602.
25. Raybould H, Koelbel CB, Mayer EA, Taché Y. Inhibition of gastric motor function by circulating corticotropin-releasing factor in anesthetized rats. J Gastrointest Motil 1990; 2: 265-72.
26. Sheldon RJ, Qi JA, Porreca F, Fisher LA. Gastrointestinal motor effects of corticotropin-releasing factor in mice. Regul Pept 1990; 28: 137-51.
27. Barquist E, Zinner M, Rivier J, Taché Y. Abdominal surgeryinduced delayed gastric emptying in rats: role of CRF and sensory neurons. Am J Physiol 1992; 262: G616-20.
28. Gourcerol G, Gallas S, Mounien L, et al. Gastric electrical stimulation modulates hypothalamic corticotropin-releasing factorproducing neurons during post-operative ileus in rat. Neuroscience 2007; 148: 775-81.
29. Naito Y, Fukata J, Tamai S, et al. Biphasic changes in hypothalamo- pituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab 1991; 73: 111-7.
30. Calogero AE, Norton JA, Sheppard BC, et al. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. Metabolism 1992; 41: 839-45.
31. Donald RA, Perry EG, Wittert GA, et al. The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomy. Clin Endocrinol (Oxf) 1993; 38: 609-15.
32. Taché Y, Barquist E, Stephens RL, Rivier J. Abdominal surgeryand trephination-induced delay in gastric emptying is prevented by intracisternal injection of CRF antagonist in the rat. J Gastrointest Motil 1991; 3: 19-25.
33. Hernandez JF, Kornreich W, Rivier C, et al. Synthesis and relative potencies of new constrained CRF antagonists. J Med Chem 1993; 36: 2860-7.
34. Barquist E, Bonaz B, Martinez V, Rivier J, Zinner MJ, Taché Y. Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats. Am J Physiol 1996; 270: R888-94.
35. Nozu T, Martinez V, Rivier J, Taché Y. Peripheral urocortin delays gastric emptying: role of CRF receptor 2. Am J Physiol 1999; 276: G867-74.
36. Luckey A, Wang L, Jamieson PM, et al. Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus. Gastroenterology 2003; 125: 654-9.
37. DeHaven-Hudkins DL, DeHaven RN, Little PJ, Techner LM. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor. Pharmacol Ther 2008; 117: 162-87.
38. De Winter BY, Boeckxstaens GE, De Man JG, et al. Effects of muand kappa-opioid receptors on postoperative ileus in rats. Eur J Pharmacol 1997; 339: 63-7.
39. Greenwood-Van Meerveld B. Emerging drugs for postoperative ileus. Expert Opin Emerg Drugs 2007; 12: 619-26.
40. Kalff JC, Schraut WH, Simmons RL, Bauer AJ. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg 1998; 228: 652-63.
41. de Jonge WJ, van den Wijngaard RM, The FO, et al. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 2003; 125: 1137-47.
42. The FO, de Jonge WJ, Bennink RJ, van den Wijngaard RM, Boeckxstaens GE. The ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of postoperative ileus in mice. Br J Pharmacol 2005; 146: 252-8.
43. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
44. Davenport AP, Bonner TI, Foord SM, et al. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev 2005; 57: 541-6.
45. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetitestimulating peptide hormone. Cell 2008; 132: 387-96.
46. Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105: 6320-5.
47. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone- releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-61.
48. Mizutani M, Atsuchi K, Asakawa A, et al. Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol 2009; 297: G974-80.
49. Jeon TY, Lee S, Kim HH, et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 2004; 89: 5392-6.
50. Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 51: 124-9.
51. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988.
52. Barreiro ML, Gaytan F, Caminos JE, et al. Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol Reprod 2002; 67: 1768-76.
53. Lu S, Guan JL, Wang QP, et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 2002; 321: 157-60.
54. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-61.
55. Bednarek MA, Feighner SD, Pong SS, et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 2000; 43: 4370-6.
56. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522.
57. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-7.
58. Guan XM, Yu H, Palyha OC, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23-9.
59. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-8.
60. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006; 494: 528-48.
61. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 2001; 86: 4284-91.
62. Schellekens H, Dinan TG, Cryan JF. Lean Mean Fat Reducing Ghrelin Machine: Hypothalamic Ghrelin and Ghrelin Receptors as Therapeutic Targets in Obesity. Neuropharmacology 2010; 58: 2-16.
63. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and desacyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-913.
64. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med 2007; 45: 565-576.
65. Stengel A, Keire D, Goebel M, et al. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 2009; 150: 5113-5118.
66. Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: Three pieces of the same puzzle. Peptides 2008; 29: 1255- 1270.
67. Gauna C, Delhanty PJ, van Aken MO, et al. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol 2006; 251: 103-11.
68. Cassoni P, Papotti M, Ghe C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 2001; 86: 1738-45.
69. Cassoni P, Ghe C, Marrocco T, et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 2004; 150: 173-84.
70. Sakata I, Yang J, Lee CE, et al. Colocalization of ghrelin Oacyltransferase and ghrelin in gastric mucosal cells. Am J Physiol Endocrinol Metab 2009; 297: E134-41.
71. Stengel A, Goebel M, Wang L, Taché Y, Sachs G, Lambrecht NW. Differential distribution of ghrelin-O-acyltransferase (GOAT) immunoreactive cells in the mouse and rat gastric oxyntic mucosa. Biochem Biophys Res Commun 2010; 392: 67-71.
72. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-9.
73. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-13.
74. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
75. Druce MR, Wren AM, Park AJ, et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 2005; 29: 1130- 6.
76. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325-8.
77. Wang L, Basa NR, Shaikh A, et al. LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am J Physiol Gastrointest Liver Physiol 2006; 291: G611-20.
78. Alvarez-Garcia O, Garcia-Lopez E, Rodriguez J, et al. Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth. Nephrol Dial Transplant 2007; 22: 1309-13.
79. Salome N, Haage D, Perrissoud D, et al. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats. Eur J Pharmacol 2009; 612: 167-73.
80. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004; 101: 4679-84.
81. Zigman JM, Nakano Y, Coppari R, et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 2005; 115: 3564-72.
82. Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002; 302: 822-7.
83. Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006; 27: 911-6.
84. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120-8.
85. Sakata I, Yamazaki M, Inoue K, Hayashi Y, Kangawa K, Sakai T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett 2003; 342: 183-6.
86. le Roux CW, Neary NM, Halsey TJ, et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005; 90: 4521-4.
87. Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 2006; 26: 11052-60.
88. Inhoff T, Wiedenmann B, Klapp BF, Mönnikes H, Kobelt P. Is desacyl ghrelin a modulator of food intake? Peptides 2009; 30: 991-4.
89. Chen CY, Inui A, Asakawa A, et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005; 129: 8-25.
90. Asakawa A, Inui A, Fujimiya M, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005; 54: 18-24.
91. Inhoff T, Mönnikes H, Noetzel S, et al. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008; 29: 2159-68.
92. Neary NM, Druce MR, Small CJ, Bloom SR. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 2006; 55: 135.
93. Toshinai K, Yamaguchi H, Sun Y, et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006; 147: 2306-14.
94. Ariga H, Tsukamoto K, Chen C, Mantyh C, Pappas TN, Takahashi T. Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach. Neurogastroenterol Motil 2007; 19: 675-80.
95. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003; 550: 227-40.
96. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 276: 905-8.
97. Yin J, Chen J. Inhibitory effects of gastric electrical stimulation on ghrelin-induced excitatory effects on gastric motility and food intake in dogs. Scand J Gastroenterol 2006; 41: 903-9.
98. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-33.
99. Ariga H, Nakade Y, Tsukamoto K, et al. Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. Regul Pept 2008; 146: 112-116.
100. Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G948-52.
101. Fukuda H, Mizuta Y, Isomoto H, et al. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 2004; 39: 1209-14.
102. Depoortere I, De Winter B, Thijs T, De Man J, Pelckmans P, Peeters T. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol 2005; 515: 160-8.
103. Tumer C, Oflazoglu HD, Obay BD, Kelle M, Tasdemir E. Effect of ghrelin on gastric myoelectric activity and gastric emptying in rats. Regul Pept 2008; 146: 26-32.
104. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetitestimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-45.
105. Dornonville de la Cour C, Lindstrom E, Norlen P, Hakanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004; 120: 23-32.
106. Kitazawa T, De Smet B, Verbeke K, Depoortere I, Peeters TL. Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 2005; 54: 1078-84.
107. Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab 2006; 91: 3296-3302.
108. Zheng J, Ariga H, Taniguchi H, Ludwig K, Takahashi T. Ghrelin regulates gastric phase III-like contractions in freely moving conscious mice. Neurogastroenterol Motil 2009; 21: 78-84.
109. Taniguchi H, Ariga H, Zheng J, et al. Endogenous ghrelin and 5- HT regulate interdigestive gastrointestinal contractions in conscious rats. Am J Physiol Gastrointest Liver Physiol 2008; 295: G403-11.
110. Binn M, Albert C, Gougeon A, et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 2006; 27: 1603-6.
111. Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54: 1693-8.
112. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 847-53.
113. Cremonini F, Camilleri M, Vazquez Roque M, et al. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology 2006; 131: 1431-9.
114. Gallas S, Sinno MH, Boukhettala N, et al. Gastric electrical stimulation increases ghrelin production and inhibits catecholaminergic brainstem neurons in rats. Eur J Neurosci 2011; 33: 276-84.
115. Fujimiya M, Itoh E, Kihara N, Yamamoto I, Fujimura M, Inui A. Neuropeptide Y induces fasted pattern of duodenal motility via Y(2) receptors in conscious fed rats. Am J Physiol Gastrointest Liver Physiol 2000; 278: G32-8.
116. Edholm T, Levin F, Hellstrom PM, Schmidt PT. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 2004; 121: 25-30.
117. Taniguchi H, Ariga H, Zheng J, Ludwig K, Takahashi T. Effects of ghrelin on interdigestive contractions of the rat gastrointestinal tract. World J Gastroenterol 2008; 14: 6299-302.
118. Tebbe JJ, Tebbe CG, Mronga S, Ritter M, Schafer MK. Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats. BMC Gastroenterol 2005; 5: 5.
119. Shafton AD, Sanger GJ, Witherington J, et al. Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation. Neurogastroenterol Motil 2009; 21: 71-7.
120. Chen CY, Chao Y, Chang FY, Chien EJ, Lee SD, Doong ML. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med 2005; 16: 695-9.
121. Hirayama H, Shiina T, Shima T, et al. Contrasting effects of ghrelin and des-acyl ghrelin on the lumbo-sacral defecation center and regulation of colorectal motility in rats. Neurogastroenterol Motil 2011; 22: 1124-31.
122. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res 2009; 19: 187-97.
123. Sibilia V, Lattuada N, Rapetti D, et al. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system. Neuropharmacology 2006; 51: 497-505.
124. Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2009; 6: 343-52.
125. Poitras P, Polvino WJ, Rocheleau B. Gastrokinetic effect of ghrelin analog RC-1139 in the rat. Effect on post-operative and on morphine induced ileus. Peptides 2005; 26: 1598-601.
126. Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B. Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus. Dig Dis Sci 2007; 52: 2241-8.
127. Popescu I, Fleshner PR, Pezzullo JC, Charlton PA, Kosutic G, Senagore AJ. The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, doseranging, placebo-controlled clinical trial. Dis Colon Rectum 2010; 53: 126-34.
128. Stengel A, Goebel M, Wang L, et al. Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor 2. Am J Physiol Gastrointest Liver Physiol 2011.
129. Satou M, Nishi Y, Yoh J, Hattori Y, Sugimoto H. Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 2010; 151: 4765-75.
130. Maruna P, Gurlich R, Rosicka M. Ghrelin as an acute-phase reactant during postoperative stress response. Horm Metab Res 2008; 40: 404-9.
131. Stengel A, Goebel M, Wang L, et al. Central administration of pansomatostatin agonist ODT-8 prevents abdominal surgeryinduced inhibition of circulating ghrelin, food intake and gastric emptying. Neurogastroenterol Motil 2011; 23.
132. Ejskjaer N, Dimcevski G, Wo J, et al. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil 2010; 22: 1069-1281.
133. Adelson DW, Kosoyan HP, Wang Y, Steinberg JZ, Taché Y. Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethaneanesthetized rats. J Neurophysiol 2007; 97: 3004-14.
134. Shrestha YB, Wickwire K, Giraudo SQ. Direct effects of nutrients, acetylcholine, CCK, and insulin on ghrelin release from the isolated stomachs of rats. Peptides 2009; 30: 1187-91.
135. Stengel A, Goebel M, Luckey A, Yuan PQ, Wang L, Taché Y. Cold ambient temperature reverses abdominal surgery-induced delayed gastric emptying and decreased plasma ghrelin levels in rats. Peptides 2010; 31: 2229-35.
136. Noble EJ, Harris R, Hosie KB, Thomas S, Lewis SJ. Gum chewing reduces postoperative ileus? A systematic review and metaanalysis. Int J Surg 2009; 7: 100-5.
137. Fitzgerald JE, Ahmed I. Systematic review and meta-analysis of chewing-gum therapy in the reduction of postoperative paralytic ileus following gastrointestinal surgery. World J Surg 2009; 33: 2557-66.